Back to top

Image: Bigstock

Compared to Estimates, Campbell (CPB) Q4 Earnings: A Look at Key Metrics

Read MoreHide Full Article

For the quarter ended July 2026, Campbell's (CPB - Free Report) reported revenue of $2.14 billion, down 7.9% over the same period last year. EPS came in at $0.39, compared to $0.62 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $2.15 billion, representing a surprise of -0.68%. The company delivered an EPS surprise of -2.5%, with the consensus EPS estimate being $0.40.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Campbell performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Net Sales- Meals & Beverages: $1.19 billion versus $1.19 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -1.3% change.
  • Net Sales- Snacks: $950 million versus $954.75 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -15.1% change.
  • Operating Earnings- Meals & Beverages: $181 million compared to the $175.84 million average estimate based on four analysts.
  • Operating Earnings- Snacks: $101 million versus $99.38 million estimated by four analysts on average.
  • Operating Earnings- Corporate: $-226 million versus the three-analyst average estimate of $-41.67 million.

View all Key Company Metrics for Campbell here>>>

Shares of Campbell have returned +3.2% over the past month versus the Zacks S&P 500 composite's +2.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Published in